STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Cencora, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cencora, Inc. (COR) President & CEO reports RSU activity. Director and executive Robert P. Mauch reported the vesting and conversion of 5,790 restricted stock units into common stock on 11/20/2025. These restricted stock units were granted for no cash consideration and are scheduled to vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027.

To cover tax withholding related to the vesting, 2,144 shares of common stock were disposed of at a price of $362.07 per share. After these transactions, Mauch beneficially owns 69,392 shares of Cencora common stock directly.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mauch Robert P.

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 M 5,790(1) A (2) 71,536 D
Common Stock 11/20/2025 F(3) 2,144 D $362.07 69,392 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(2) 11/20/2025 M 5,790(1) (2) (2) Common Stock 5,790(1) $0 13,158 D
Explanation of Responses:
1. Includes vesting of 579 restricted stock units with delivery of shares of common stock deferred until after retirement or other termination of employment.
2. Grant of Restricted Stock Units received for no consideration that vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027.
3. Satisfaction of tax withholding obligation incident to the vesting of restricted stock units.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Robert P. Mauch 11/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cencora (COR) disclose in this Form 4 filing?

The filing reports Robert P. Mauch, Cencora’s President & CEO and director, vesting 5,790 restricted stock units and related share withholding for taxes on 11/20/2025.

How many Cencora (COR) restricted stock units vested for the CEO?

5,790 restricted stock units vested and were converted into Cencora common stock, as shown in both the non-derivative and derivative securities tables.

How are the Cencora (COR) restricted stock units scheduled to vest?

The restricted stock units were granted for no consideration and vest in three equal installments on 11/20/2025, 11/20/2026 and 11/20/2027.

How many Cencora (COR) shares were sold to cover taxes?

The filing shows a disposition of 2,144 shares of Cencora common stock at $362.07 per share, identified as satisfying tax withholding obligations from RSU vesting.

How many Cencora (COR) shares does the CEO own after these transactions?

Following the reported transactions, Robert P. Mauch beneficially owns 69,392 shares of Cencora common stock directly.

What is the relationship of the reporting person to Cencora (COR)?

The reporting person, Robert P. Mauch, is both a Director and an Officer, serving as President & CEO of Cencora, Inc.

Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.49B
185.78M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN